JBHT — J.B. Hunt Transport Services, Inc.

The tape as of 2026-10-16 is unambiguously negative: JBHT is down 13.8% over one month and 21.2% over three months, sits 6.8% below its 50-day and 3.9% below its 200-day moving average, and sentiment was reset twice in five weeks - first by the mid-September negative guidance warning, then by post-Q3 target cuts (Bernstein $329 to $307, Wells Fargo $335 to $305, Baird $320 to $290, Citi $309 to $254). The 2026-10-15 print actually beat on revenue ($3.68B vs ~$3.59B consensus) with intermodal loads up 8%, but the market focused on the ~$50M expense overrun - fuel, driver recruiting, group medical claims, purchased transportation - that held operating income growth to 2% on 20.4% revenue growth and cut diluted EPS growth to 3%.

Three phases are visible in the trailing twelve quarters. (1) Freight recession, 2023-2025: revenue fell 4.8% YoY in Q4 2024 and 0.5% in Q3 2025, and diluted EPS bottomed at $1.17 in Q1 2025 (-4.1% YoY versus $1.22 in Q1 2024). (2) Volume-led inflection: revenue YoY turned +4.6% (Q1 2026), +19.4% (Q2 2026), +20.4% (Q3 2026), and EPS YoY ran +24.2% (Q4 2025), +27.4% (Q1 2026), +45.8% (Q2 2026) as operating leverage finally appeared - Q2 2026 operating margin was 7.42% versus 6.74% a year earlier. (3) The Q3 2026 break: EPS growth collapsed to +3.4% and operating margin fell to 6.72% from 7.95% (a 123bp YoY contraction), the first YoY margin decline since Q1 2025, on the ~$50M cost overrun. Read this as a cost blip inside a genuine volume-led recovery rather than a structural rollover - but one that must not repeat in Q4 for the recovery thesis to hold. One genuine caution underneath the revenue headline: operating cash flow was down YoY in both Q1 2026 (-12.7%, $353.0M vs $404.2M) and Q2 2026 (-7.9%, $370.2M vs $402.1M), so the volume surge is not yet converting into more cash.

Not cheap. As of 2026-10-16, JBHT traded at 32.3x trailing EPS of $7.143, 5.95x book, 1.62x sales and 13.9x EV/EBITDA, versus its own 5-year averages of 27.5x P/E and 1.52x P/S - roughly a 17% premium on earnings. The forward math is no better: consensus next-FY EPS of $7.282 puts the forward P/E at ~31.6x, essentially identical to the trailing multiple, meaning investors are paying a full price for earnings forecast to grow only ~2%. EV/EBITDA of 13.9x is well above the 7-10x typical of trucking and logistics peers. PEG of 1.41 implies a far rosier long-run growth assumption than the sell-side EPS line does. The honest bull case requires a normal-cycle EPS recovery toward $8.50-9.00, which still leaves the stock at 26-27x. Fairly valued at best, expensive against what is currently being delivered.

The stock is discounting a recovery that has not reached the income statement yet. Q3 2026 showed volumes are back but price/cost is not: 20.4% revenue growth produced 2% operating income growth. If the ~$50M of Q3 cost overruns is genuinely transitory, normalized Q3 EPS was closer to $2.20 and the story flips to a growth stock - that is the bull case for paying ~32x. If fuel, driver wages and medical/casualty inflation are structural, FY2027 EPS stays near $7.30 and the multiple compresses toward the 5-year 27.5x, implying roughly $200. Note the 24% gap between the $229.92 price and the $285 consensus target: at that target the stock would trade at ~39x the same analysts' FY2027 EPS estimate. Treat the consensus target as an underwriting of normal-cycle earnings their own EPS estimates do not yet show, not a base case.

As of 2026-10-16, RSI-14 was 47.3 - dead neutral, neither oversold nor overbought, so there is no mean-reversion edge here. Price at $229.92 sat 2.3% above the 20-day (~$225), 6.8% below the 50-day (~$247) and 3.9% below the 200-day (~$239); returns were +3.0% over one week but -13.8% over one month and -21.2% over three months, with the six-month figure a modest -1.3%. That is a short-term bounce inside an intermediate downtrend, with price below both major moving averages. Practical implication: no technical reason to chase the bounce; a reclaim of the 50-day would be the first evidence of a trend change, while the 52-week low of $157.82 is the downside reference if cost pressure persists into Q4.

• Diesel near or above $6/gal is inflating both fuel surcharge revenue and purchased-transportation/fuel expense, adding reported-margin volatility that lags through contractual pass-through.
• Driver and non-driver labor inflation plus rising group medical and casualty claims are structural cost headwinds - all four were explicitly cited by JBHT in Q3 2026.
• The freight cycle is past its trough: intermodal loads rose 8% in Q3 2026 and the 2027 bid season opened with low-single-digit price gains, which helps volumes but not yet yield.
• Rail and intermodal competition - BNSF/NS service quality, new CPKC-CSX-FXE Mexico lanes - plus a lingering truckload capacity overhang both cap JBHT's pricing power.
• Import volumes, tariff regime and cross-border trade policy directly drive transcontinental intermodal demand, JBHT's core lane structure.

• The 2027 intermodal bid season: currently pricing at low-single-digit gains, and the single biggest swing factor for FY2027 yield and margin recovery.
• Whether the ~$50M Q3 2026 cost overrun reverses - the next print (2027-01-21, estimated) is the key test of whether the margin trend re-establishes.
• Peak retail shipping season volumes through Q4 2026, which either confirm or undercut the +8% intermodal load growth.
• Continued truckload capacity exits (carrier failures and fleet reductions) tightening spot and contractual pricing into the recovery.
• Normalization across fuel, driver recruiting and medical/casualty claims, which would let 20% revenue growth fall through to profit.

• Revenue growth without profit growth: Q3 2026 revenue +20.4% against operating income +2%. If cost inflation is structural, operating leverage never arrives and the recovery narrative breaks.
• Valuation compression: ~32x trailing and ~31.6x forward earnings against ~2% consensus FY2027 EPS growth leaves no cushion; a de-rating to the 5-year 27.5x average on flat earnings implies roughly $200.
• Pricing power: if the 2027 bid season settles at low-single-digit gains while purchased transportation and wages keep climbing, JBHT fails to pass through inflation a second year running.
• Thin capital returns on an asset-heavy model: ROIC of 9.3% barely clears an estimated ~8.5% cost of capital while capex runs roughly $500M a year, so incremental volume may not create value at current margins.
• Unhedgeable operating inflation: fuel, driver recruiting and especially group medical/casualty claims are the hardest cost lines to control and were the direct cause of the Q3 2026 miss.

J.B. Hunt is a genuinely good franchise - intermodal scale, a dedicated-contract book, an asset-light brokerage/360 platform, 16.8% ROE and roughly $1.1B of trailing free cash flow - stuck in the awkward middle of a freight recovery where volumes and revenue are inflecting hard (+20.4% in Q3 2026) while cost inflation keeps earnings flat (+3% EPS). At ~32x trailing and ~31.6x forward earnings against ~2% consensus EPS growth, and with ROIC of 9.3% barely above cost of capital, the price already assumes a margin recovery that has not shown up. This is not a value trap and not a bargain: it is a fairly-to-fully valued high-quality cyclical whose direction will be decided by two datapoints - Q4 cost normalization and 2027 bid season pricing.

Applied 28x - a discount to the ~32x trailing multiple and just above the 27.5x five-year average, warranted by the intermodal franchise but capped by 9.3% ROIC - to a normalized forward EPS of $7.90, built from consensus FY2027 EPS of $7.282 plus roughly $0.40 of the Q3 2026 $50M cost overrun I treat as transitory and a small operating-leverage contribution from 8% intermodal load growth on low-single-digit pricing (28x x $7.90 = $221). Cross-checked with a simple FCF-based valuation: ~$1.05B normalized free cash flow grown at 6% with a 3.5% terminal rate and an 8.5% WACC implies roughly $233, so the two methods blend to $224.